Clinical outcomes in patients with faster advancing MS treated with teriflunomide in TEMSO and TOWER

被引：0
|
作者：
Kappos, L. [1 ]
Thangavelu, K. [2 ]
Cavalier, S. [2 ]
Truffinet, P. [3 ]
Comi, G. [4 ]
Miller, A. [5 ]
机构：
[1] Univ Hosp Basel, Basel, Switzerland
[2] Sanofi Genzyme, Cambridge, MA USA
[3] Sanofi Genzyme, Chilly Mazarin, France
[4] Univ Vita Salute San Raffaele, Milan, Italy
[5] Icahn Sch Med Mt Sinai, New York, NY 10029 USA
来源：
EUROPEAN JOURNAL OF NEUROLOGY | 2016年 / 23卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P11185
引用
收藏
页码：197 / 197
页数：1
相关论文
共 50 条
  • [1] Long-term Disability Outcomes in Teriflunomide-Treated Patients in TEMSO and TOWER: An Analysis Utilizing the Topographical Model of MS
    Krieger, Stephen
    Freedman, Mark S.
    Miller, Aaron E.
    Truffinet, Philippe
    Thangavelu, Karthinathan
    Mandel, Matt
    Lublin, Fred
    [J]. NEUROLOGY, 2018, 90
  • [2] Predicting long-term disability outcomes in patients with MS treated with teriflunomide in TEMSO
    Sormani, Maria Pia
    Truffinet, Philippe
    Thangavelu, Karthinathan
    Rufi, Pascal
    Simonson, Catherine
    De Stefano, Nicola
    [J]. NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION, 2017, 4 (05):
  • [3] Teriflunomide efficacy in subsets of patients with relapsing MS: results from TEMSO and TOWER studies
    Comi, G.
    Thangavelu, K.
    Truffinet, P.
    Rufi, P.
    de Seze, J.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2015, 21 : 535 - 536
  • [4] Teriflunomide safety in subsets of patients with relapsing MS: results from the TEMSO and TOWER studies
    Comi, G.
    de Seze, J.
    Thangavelu, K.
    Truffinet, P.
    Benamor, M.
    Rufi, P.
    Kappos, L.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2015, 21 : 541 - 541
  • [5] Long-term disability outcomes in teriflunomide-treated patients in TEMSO and TOWER: an EDSS and FSS categorical analysis
    Lublin, F.
    Miller, A.
    Truffinet, P.
    Thangavelu, K.
    Mandel, M.
    Freedman, M. S.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2017, 23 : 903 - 903
  • [6] Pregnancy outcomes in patients with MS treated with teriflunomide: clinical study data
    Vukusic, S.
    Coyle, P. K.
    Jurgensen, S.
    Truffinet, P.
    Benamor, M.
    Poole, E.
    Chavin, J.
    Chambers, C.
    [J]. EUROPEAN JOURNAL OF NEUROLOGY, 2018, 25 : 534 - 534
  • [7] Long-term Efficacy and Safety Outcomes of Teriflunomide Treatment in TEMSO and TOWER
    Oh, Jiwon
    Freedman, Mark S.
    Benamor, Myriam
    Poole, Elizabeth
    Chavin, Jeffrey
    Comi, Giancarlo
    [J]. NEUROLOGY, 2018, 90
  • [8] Pregnancy Outcomes in Patients With MS Treated With Teriflunomide: Clinical Study and Postmarketing Data
    Vukusic, Sandra
    Coyle, Patricia K.
    Jurgensen, Stephanie
    Truffinet, Philippe
    Benamor, Myriam
    Poole, Elizabeth
    Chavin, Jeffrey
    Chambers, Christina
    [J]. NEUROLOGY, 2018, 90
  • [9] Pregnancy Outcomes in Patients with MS Treated with Teriflunomide: Clinical Study and Postmarketing Data
    McCombe, P.
    Vukusic, S.
    Coyle, P. K.
    Jurgensen, S.
    Truffinet, P.
    Benamor, M.
    Poole, E.
    Chavin, J.
    Chambers, C.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2019, 25 (03) : 474 - 475
  • [10] Outcomes of the TEMSO extension study of teriflunomide: 10.5 years of clinical results
    Freedman, M. S.
    Miller, A. E.
    Comi, G.
    Kappos, L.
    LeBrun-Frenay, C.
    Truffinet, P.
    Purvis, A.
    Benamor, M.
    Wolinsky, J. S.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2016, 22 : 334 - 335
12345